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Phosphorylase kinase (Phk), a key regulatory enzyme in glycogenolysis, is a
hexadecameric protein that contains four different subunits with a stoichiometry (αβδ)4.
Alpha and β are regulatory subunits,  is catalytic and δ is an intrinsic molecule of
calmodulin. The gene that encodes for the subunit PHKG1 undergoes alternative
processing to produce a truncated form of  containing 181 residues (181) instead of the
normal 387 residues. Although much of the kinase helical domain is absent, 181 is still
catalytic with its activity being influenced by PKC, and its mRNA being expressed in
high levels in brain. S peptide is the only known in vitro substrate for 181. In the
present study, we are using the LexA-based yeast two-hybrid system to identify binding
partners for 181. Gamma181 was cloned into the pLexA vector and used as bait to
screen a human fetal brain cDNA library. Interactions between 181 and cDNA library
proteins were monitored by auxotropic growth of the yeast in the absence of leucine and
by expression of -galactosidase activity. Following screening for leucine prototrophy
and -galactosidase activity, we obtained 37 colonies that show positive for leucine
prototrophy, although only 20 of these colonies were -galactosidase positive. Among
these 20 colonies, 7 unique clones were identified corresponding to the proteins RPL23,
RPL9, and NA14. The physiological relevance of these interactions in the brain is yet to
v

be discovered.

vi

Introduction

A. Phosphorylase kinase
Phosphorylase kinase (Phk), the first protein kinase discovered, belongs to the
serine/threonine kinase super family. Phk, a key regulatory enzyme of glycogenolysis, is
a hexadecameric protein that contains four different subunits with a stoichiometry of
(αβγδ)4 and molecular mass of 1.3x106 Da (Brushia and Walsh, 1999; Cohen, 1973).
Alpha and β are regulatory subunits, γ is catalytic (Skuster et al., 1980) and δ is an
intrinsic molecule of calmodulin which binds tightly to the holoenzyme (Cohen et al.,
1978; Grand et al., 1981).
Phosphorylase kinase has a vast diversity of expression levels in different tissues
with liver and muscle having higher amounts. Determination of the spatial expression
pattern of the Phk subunits by Expressed Sequenced Tag (EST) and UniGene database
analysis revealed that Phk may be expressed in 28-36 different tissues (Winchester et al.,
2007). In muscle cells Phk exists in two different compartments. The bulk of the
enzyme is located in the cytoplasm and is associated with the glycogen particles (Meyer
et al., 1970). Studies on localization of phosphorylase kinase revealed that a fraction of
the Phk is directly associated with the membranes of T-tubules and sarcoplasmic
reticulum of muscle cells (Thieleczek et al., 1987 and Dombradi et al., 1984).
Farnesylation of the

and

subunits of Phk provided additional evidence for association

of Phk with the membrane in muscle cells (Heilmeyer et al., 1992). Even though all of
the enzyme molecules get farnesylated, only a small amount of Phk appears to be
associated with the membranes.

3

4
Structurally, Phk is a complex enzyme made up of 16 subunits. Three dimensional
structural studies of the Phk by cryo-electron microscopy (Bryan et al., 2009), negative
staining, and scanning transmission electron microscopy (Trempe et al., 1986) reported a
bilobal form of the enzyme also know as the butterfly like view (Fig.1.1). Eighty percent
of the total mass of the enzyme is composed of the

and

subunits, thus

and

are the

major contributors to the overall 3-D structure of Phk.

Fig. 1.1. Schematic location of the four subunits in the 3-D Cryo-EM volume of
phosphorylase kinase holoenzyme (Venien-Bryan et al., 2009).

In the butterfly like structure, Phk has two lobes which are connected at the center
of the lobe by two bridges. The

subunit of Phk is located at the wing tips of the

butterfly orientation of the holoenzyme (Wilkinson D.A., 1994). Proteolytic degradation
of the

subunit by trypsin disrupts the butterfly structure of the holoenzyme whereas

proteolysis of
that

subunit has little effect on the structure of Phk. This supports the idea

is required to maintain the integrity of the structure, and it forms the bridge

between the two lobes (Trempe et al., 1986). Phk protein crosslinking results in the
formation of
formed by the

dimers which further supports that each bridge in the holoenzyme was
dimer (Ayers et al., 1998).
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The

as well as

holoenzyme. The

subunits of Phk are well known for their regulatory roles in the

subunit has 1237 amino acids with a molecular mass of 138 KDa

(Zander et al., 1988). There are two separate genes encoding the two isoforms of the
subunit, and a single gene encoding the multiple isoforms of the
two forms of the muscle specific

subunit. Additionally,

subunit exist as a result of alternative splicing of the

PHKA1 gene; the truncated form lacks 59 amino acids in the middle of the polypeptide
(Harmann et al., 1991). In the nonactivated holoenzyme, quaternary interactions of the
and

subunits inhibit the catalytic activity of the subunit (Paudel and Carlson, 1987).

The presence of highly conserved glucoamylase like domains in the

and

subunits

suggests a functional role for these subunits in release of glucose from the nonreducing
ends of glycogen in addition to the regulation of the Phk holoenzyme (Pallen, 2003).
Extrinsic calmodulin, also known as ’, also activates the Phk by directly binding to the
and

subunits. This activation purely depends on the presence of calcium. The ’

subunit will not activate the tryptic and chymotryptic digests of Phk which provides
evidence for interaction of the ’ subunit with the ,
The
1986). The

subunits (Picton et al., 1980).

subunit maintains the structural integrity of the holoenzyme (Trempe et al.,
subunit consists of 1029 amino acid residues and has two serine

phosphorylation sites, -26 and -700 that are good substrates for protein kinase A
(Heilmeyer, 1991). Residues 420-436 of the

subunit contain a region that has sequence

homology with the natural substrate glycogen phosphorylase b (Pb) which acts as an auto
inhibitor and regulates the activity of the subunit (Sanchez and Carlson, 1993).
Phosphorylation and farnesylation are the two post translational modifications that occur
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on the

and

subunits. The exact function of farnesylation of the

and

subunits in

vivo is unknown. A cluster of 7 phosphorylation sites (aka multiphosphorylation domain)
was identified in the

subunit.

The subunit of phosphorylase kinase has a molecular mass of 41,000 daltons
(Cohen, 1973) and harbors the catalytic site. The N-terminus of the subunit (amino
acids 1-298) shares extensive sequence homology with the catalytic domain of most
kinases, whereas the C-terminal region (last 110 amino acids) shows sequence homology
with the calmodulin dependent kinase troponin I.
1

20
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binding
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Kinase catalytic
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Kinase catalytic
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Fig. 1.2. Schematic representation of the subunit of phosphorylase kinase
(Owen et al., 1995).

The C-terminus of the subunit mediates the interaction with the and

subunits. The

subunit has two noncontiguous calmodulin binding sites, 302-326 and 342-366. Both
of these are rich in positively charged amino acids and bind to the subunit
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simultaneously (Dasgupta et al., 1989). Electrostatic interactions play an important role in
the interaction between the and subunits because there is a drastic reduction in the
activation of the subunit by the subunit when the acid residues in the E helices of the
subunit are changed to basic residues (Farrar et al., 1993). The C-terminal region of the
subunit (residues 302-312) acts as an auto inhibitory region. In vitro studies with a
peptide corresponding to amino acids 302-312 have shown that this peptide binds to the
catalytic site of a truncated subunit (1-300) and acts as an inhibitor. This peptide called
Phk13-1, also decreases the ATPase activity of the truncated (1-300) (Bartleson &
Graves., 2001). Yeast two-hybrid and protein crosslinking studies by Rice et al., (2002)
showed the C-terminus of the

subunit (amino acids1060-1237) interacts with the C-

terminus of the subunit (amino acids 343-386). Furthermore, there is an increase in
heterodimer formation in the presence of Ca2+ which reveals that Ca2+indirectly mediates
changes in the interaction between the

and subunits (Rice et al., 2002). Studies with a

purified subunit show high catalytic activity even in presence of EGTA, suggesting that
Ca2+ is not required for the purified subunit of Phk to maintain its activity (Skuster et
al., 1980). The purified subunit also phosphorylates well-known in vitro substrates of
Phk such as myelin basic protein, k-casein, skeletal muscle troponin complex and
troponin T. Free Mg2+ activates the subunit whereas free Mn2+ inhibits the activity
(Kee and Graves, 1987). By using two different database searches Winchester et al.,
(2007) showed that the , , and subunits undergo extensive posttranscriptional
processing. The PHKG1 gene which encodes the subunit of Phk, undergoes alternative
cleavage and polyadenylation in intron 6 which results in the formation of a truncated
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form of the subunit resulting in 181 amino acids instead of the normal 387 amino acids.
The transcriptional expression level of this truncated form of is proposed to be high in
the brain (Winchester et al., 2007).
The subunit of Phk consists of a single polypeptide of 148 amino acids with a
molecular weight of 16,680 daltons (Grand et al., 1981). It is an intrinsic molecule of
calmodulin that confers the Ca2+ sensitivity to Phk, and it associates tightly with the
subunit even in the absence of Ca2+ (Picton et al., 1980). While unusual, this is not an
exceptional case because it has been shown that adenylate cyclase from the bacterium B.
pertusis has two calmodulin binding domains and associates with calmodulin even in the
absence of Ca2+, which helps to protect the adenylate cyclase from proteolytic
degradation (Ladant, 1988). In addition to this, the subunit also provides a stabilizing
role in Phk and prevents the aggregation of the

and

subunits in the holoenzyme

thus confining the number of protomers of Phk (Paudel & Carlson, 1990). It also plays a
dual role in the holoenzyme. In the absence of calcium, it inhibits Phk activity, and in the
presence of calcium it activates Phk (Hessova et al., 1985) suggesting a tight association
of the subunit with the enzyme even in the absence of calcium. Purified subunit, as
well as the holoenzyme, activates phosphodiesterase and myosin light chain kinase in the
presence of calcium and confers calcium sensitivity to the holoenzyme is provided by the
subunit.
Glycogen phosphorylase b (Pb) is the only known in vivo substrate for Phk, even
though myelin basic protein, k-casein, and skeletal muscle troponin complex and
troponin T are known to be phosphorylated by Phk in vitro (Pickett-Gies and walsh, 1986
a). Recent studies by Boulatnikov et al., (2008) showed that glyceraldehyde3-phosphate
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dehydrogenase (G-3DH), an intermediatory enzyme in glycolysis, is also phosphorylated
by Phk, and its phosphorylation activity depends upon Ca2+and pH. Interaction of G3DH with Phk provides evidence for the direct link between glycogenolysis and
glycolysis (Boulatnikov et al., 2008).
Regulation of Phk in relation to its function is a highly complex process. Phk
activity is well regulated by the extracellular hormone epinephrine and also Ca2+.
Epinephrine is known to activate glycogenolysis in skeletal muscle. The downstream
targets in the epinephrine signaling pathway are protein kinase A, Phk, and Pb (Yeaman
and Cohen, 1975). Epinephrine triggers the activation of Pb thus providing the energy for
the cell to meet the requirements of muscle contraction. The holoenzyme itself is
regulated by the autoinhibitor sequences present in the

and subunits which bind to the

catalytic site resulting in inhibition of the phosphotransferase activity. Phosphorylation of
both the

and

subunits by cAMP dependent kinases regulates the phosphotransferase

activity of Phk (Ramachandran et al., 1987). Even though there is no evidence for
autophosphorylation of Phk in vivo, in vitro studies showed that autophosphorylation of
the regulatory subunits by Phk itself increases its specific activity (Hallenbeck and
Walsh, 1983). In vitro studies have revealed that the phosphotransferase activity of the
Phk holoenzyme is highly dependent on pH changes, whereas the purified

complex is

less dependent. With an increase in pH from 6.8 to 8.2, the activity also increases (Chan
and Graves, 1982). The exact mechanism of how increases in pH relieve the inhibition of
the holoenzyme by the regulatory subunits is not known.

As previously discussed, Ca+2 is also known to be a major regulator of the
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phosphotransferase activity of Phk. Calcium enhances the activity of the enzyme by
directly binding to the

subunit. Extrinsic calmodulin, ’ is also known to activate

(Pickett-Gies and Walsh, 1986 b) the enzyme by binding to the

and

subunits (Picton

et al., 1980). Both extrinsic and intrinsic calmodulin molecules depend upon on Ca2+for
Phk activation. Limited proteolysis of the

and

subunits by trypsin raises the enzyme

activity at pH 6.8 (Cohen, 1973).

B. Protein-protein interactions and the Yeast Two-Hybrid System
Protein-protein interactions are a fundamental phenomenon for majority of
cellular function. The majority of biological processes such as DNA replication,
transcription, translation, and splicing depend on the interaction between specific proteins
in the cell. Several enzymes including hemoglobin, the pyruvate dehydrogenase complex,
Phk, and RNA polymerase all have multiple subunits. Interactions among the individual
subunits are highly specific and are very important for the enzymatic functions and
regulation. In addition to this, several transient protein-protein interactions also exist
within the cells which regulate processes such as signal transduction, metabolic
pathways, and cell cycle regulation. Transient protein-protein interactions are observed
between protein modifying enzymes such as kinases, phosphatases, glycosylases, and
their substrates. Interaction between proteins or among the subunits of enzymes has
several effects within the cell. One such major effect of protein-protein interactions is
dynamic changes in the kinetic properties of the enzymes. For example, in the
nonactivated holoenzyme, quaternary interactions of the

and

subunits inhibit the
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catalytic activity of the subunit of Phk (Paudel and Carlson, 1987).
Sequencing the human genome and assigning function to the newly identified
gene products is one of the biggest challenges for biologists today. One of the best ways
to determine function of newly identified gene products is to study the protein with which
it is interacting in the cell. Therefore, understanding protein-protein interactions that
occur within the cell is very crucial. Several biochemical and genetic methods have been
developed to study protein-protein interactions. Commonly used biochemical techniques
to study protein-protein interactions in vitro are co-immunoprecipitation, cross linking,
and affinity blotting. Genetic methods such as the yeast two-hybrid system and phage
display are also widely used to study protein-protein interactions in vivo (for review see
Phizicky and Fields, 1995). Extensive research on the eukaryotic transcription factor
Gal4 was a breakthrough for the development of the yeast two-hybrid system. Gal genes
are required for the growth of the yeast cells on galactose medium, and consist of the Gal
1, 7, 2, 10 structural genes and the Gal 3, 4, 80 regulatory genes. Gal4 is an important
transcriptional activator that regulates the transcription of the Gal 1, 7, 10 structural genes
by binding to the upstream activator sequences (for review see Traven et al., 2006). The
Gal4 transcriptional activator has a DNA binding domain and an activation domain; these
two domains can be separated from each other physically and functionally. This was
shown by fusing the -galactosidase encoding lacZ gene to the Gal4 DNA binding region
followed by the detection of the gal4- -galactosidase fusion protein in yeast cells. The
fusion protein was localized to the nucleus. Silver et al., (1984) also showed that only the
74 N- terminal amino acids are required for sufficient nuclear localization of the gal4- galactosidase fusion protein. The N-terminal 1-98 amino acid region of this DNA
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binding (BD) domain alone will not activate the transcription (Keegan et al., 1986).

B
A

C

Fig. 1.3 Schematic representation of the yeast two-hybrid system. A. The coding
sequence of bait protein (X) is cloned into BD containing vector which expresses BD-bait
fusion protein B. Coding sequence of prey protein is cloned into an activation domain
containing vector which express the AD-prey fusion protein C. Interaction of protein X
with protein Y results in the reconstitution of the transcription factor and expression of
the reporter gene. (Promega protein interaction guide, Chapter 1, yeast two-hybrid
system, pp 1-3).
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The functional activity of the separated DNA binding (BD) and activation domain
(AD) of the Gal4 transcription factor was also later demonstrated by constructing the
Gal80-AD fusion protein which was able to activate the transcription of downstream
targets that are under the control of UASG by interacting with the Gal4 transcription
factor. Thus, the BD and AD do not need to be in the same polypeptide for them to
function (Ma & Ptashne, 1988). If the BD and AD are physically separated and they do
not interact with each other, they will not activate transcription of the genes. However, if
the BD and AD are physically close to each other, they will activate transcription. This
was first shown by Fields and Song (1989). In their work, the Gal4 BD and the Gal4 AD
were fused to the well characterized interacting proteins SNF1 and SNF4, respectively,
and then transferred into yeast cells. Interaction between these two proteins, SNF1 and
SNF4, resulted in the BD and AD being physically close to each other. Positive
transcriptional activation was measured by -galactosidase activity of the Gal1- galactosidase fusion protein (Fields and Song, 1989).
The yeast two-hybrid system has advantages over classical biochemical
techniques such as co-immuno precipitation, cross linking, and affinity blotting. One of
the major advantages is that it uses yeast cells as host cells, which have greater
resemblance to higher eukaryotes. Also, transient interactions that occur in the cell are
relatively weak, and such weak interactions can be detected in the yeast two-hybrid
system. By using the yeast two-hybrid system the strength of interaction between the
interacting proteins can also be measured (Sobhanifar, 2003). By using this system, any
protein of interest termed a “bait” protein, can be screened against library proteins fused
to AD to identify new binding partners for the bait (Chien et al., 1991).
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Even though the yeast two-hybrid system is extensively used to study proteinprotein interactions, it has some limitations. Posttranslational modification such as
glycosylation occurs in the endoplasmic reticulum. As all the fusion proteins are targeted
to the nucleus, interactions that depend upon post translational modifications cannot be
detected in the yeast two-hybrid system. Thus, it has limitations for the use in detecting
associations with extracellular and membrane associated proteins (Allen et al., 1995).
Also, fusion proteins which are used in the two-hybrid system may change the
conformation of the bait or prey, resulting in alteration of the binding activity of the
proteins (Sobhanifar, 2003).
The first two-hybrid method developed was based on the Gal4 transcription factor
(Fields and Song, 1989). In the Gal4 dependent yeast two-hybrid system, the yeast strain
used for this study carried a deletion of the Gal4 and Gal80 genes, and grew more slowly
than the wild-type strain. In order to avoid such problems, the LexA based method, also
known as “interaction trap”, was developed (Golemis et al., 2008). LexA is a repressor
protein (Ebina et al., 1983) that represses the transcription of the several SOS genes in
E.coli. Brent and Ptashne (1984) showed that the LexA protein expressed in yeast cells
was passively transported into the nucleus and repressed the transcription of Gal1
promoter derivatives containing at least two LexA operators.
In the LexA-based system, nutritional markers used for selection are different
from other two-hybrid systems. The bait plasmid contains the LexA DNA BD, and it is
maintained in the cells by the presence of the HIS3 gene which confers histidine
prototrophy to the cells. The prey plasmid contains the B42 AD, and cDNA is inserted
into the prey plasmid so that it will express cDNA-B42 AD fusion proteins. The prey
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plasmid is maintained by the presence of the TRP1 gene conferring the ability to grow in
the absence of tryptophan. The AD fusion protein produced in the cell is under the
control of the GAL1 promoter, whose expression is induced by growing the cells in
medium which contains galactose/raffinose. AD fusion protein levels are tightly
regulated by this inducible promoter. This kind of regulation allows the cells to protect
the normal cellular functions from the toxic fusion proteins. A low background
LexAoperator-LEU reporter gene which is located on the chromosomal DNA is used to
monitor the protein-protein interactions. It has six LexA operators upstream of the LEU2
gene. The second reporter gene LexAoperator-LacZ is maintained on the URA3 (uracil
prototrophy) based plasmid. This plasmid has eight LexA operators upstream of the LacZ
gene (Bartel and Fields, 1997). This kind of dual selection method makes the yeast twohybrid system more reliable by reducing the number of false positives (Allen et al, 1995).
The LexA repressor tagged bait fusion protein potentially reduces auto activation of the
reporter genes (Allen et al., 1995).
Protein-protein interactions are monitored in vivo by leucine prototrophy and
LacZ expression. The second reporter gene monitors LacZ gene expression in the cells
which makes the -galactosidase enzyme. Its activity can be measured by using different
substrates. The most commonly used substrate is 5-bromo-4-chloro-3-indolyl-beta-Dgalactopyranoside (X-gal). Beta-galactosidase converts the colorless substrate, X-Gal,
into a blue color product. A more sensitive -galactosidase assay uses the substrates
ONPG and 1, 2 dioxetane which allow for measurement of the strength of the interactions
quantitatively (Gietz et al., 1997).
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C. Rationale of the project
Phk is a highly complex enzyme consisting of 16 protomers. Regulation of the
phosphotransferase activity of Phk is a highly complex process. Extensive research has
been carried out to understand the interaction of the protomers of the Phk and their role in
the regulation of phosphotransferase activity. Understanding the spatial distribution of
Phk is also very important. Winchester et al., (2007) showed by using EST and Uni Gene
databases that Phk is expressed in nearly 28-36 different tissues, and that the

and

subunits undergo extensive alternative transcriptional processing. In addition, they also
found that there is a weak polyadenylation signal in intron6 of the gene which encodes
for the subunit, PHKG1. An intronic polyadenylation signal will allow for alternative
processing of the mRNA corresponding to the subunit. In silico translation of the
alternatively processed mRNA resulted in a subunit with 181 amino acids ( 181)
followed by an additional 21 amino acids which are derived from the intronic region.
These unique C terminal 21 amino acids are highly conserved among primates.
Biochemical evidence also showed that 181 mRNA is expressed in the brain, heart,
skeletal muscle, and tongue with brain having the higher levels (Winchester et al., 2007).
The truncated form of the subunit lacks residue E 182 which determines the specificity
of the enzyme for the Phb substrate. Furthermore the prosite database revealed that the
unique 21 amino acids at the C-terminus of 181 has a putative protein kinase C (PK-C)
phosphorylation site. Surprisingly, despite being truncated, recombinantly expressed 181
retains its kinase activity toward a peptide substrate, and this activity depends upon
phosphorylation of 181 by PK-C (Unpublished data). In vivo substrates are currently not
known for the 181 subunit. In this study we have used the LexA based yeast two-hybrid
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system to identify potential binding partners for 181 in the brain.

MATERIALS AND METHODS

A. Yeast and bacterial strains
The yeast strain used for the yeast two-hybrid screening was EGY 48 (MAT a,
his3, trp1, ura3, 6ops-Leu2) (Clontech, Mountain View, CA). All plasmid manipulations
were carried out in E. coli strain DH5. The brain cDNA library was amplified in the
high efficiency transformation strain DH10B ( MegaX DH10B™ T1R Electrocomp™
Cells, Invitrogen). All of the library plasmids were rescued in the E. coli strain KC-8
(hsdR, leuB600, trpC9830, pyrF::Tn5, hisB463, lacΔX74, strA, galU,K).

B. Two hybrid plasmids
pLexA, pB42, pJK101, and p8op-LacZ plasmids were used for this study (Table
1). All of the basic plasmids were obtained from Clontech (Clontech, Mountain View,
CA). The pLexA basic vector (Fig. 2.1) was used for cloning the coding sequence of the
bait protein. Other constructs cloned into the pLexA vector were p53, and the Drosophila
bicoid protein coding sequence. The ADH1 promoter controls the expression of LexA
fusion proteins. HIS3 is the marker used for selection in the yeast. The pB42 AD vector
was used for cloning the cDNA library. A human fetal brain cDNA library cloned into
the pB42 vector (Fig. 2.2) was kindly provided by Dr. Erica Golemis of Fox Chase
Cancer Center, Philadelphia, PA. The GAL1 promoter controls the expression of the
B42-cDNA cassette. The cassette also included a nuclear localization signal for targeting
the B42-prey fusion proteins to the nucleus and a hemagglutinin epitope tag for
assessment of the size of the encoded protein. This vector also has a TRP1 marker for
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selection in the yeast cells. The p8op-LacZ plasmid (Fig. 2.3) is the most sensitive
reporter plasmid used in the LexA based two-hybrid system. It has eight LexA operators
followed by the LacZ reporter gene. It has a URA3 marker for selection in yeast cells.
Other plasmids used in this study include, pJK101, pRFHM1, and pLexA-POS plasmids
which were used for the repression assay. The pJK101 plasmid has an UASG followed by
the LexA operator sequence followed by LacZ reporter gene. It has URA3 marker for
selection in the yeast cells. pRFHM1 expresses LexA-bicoid fusion proteins used as a
positive control in the repression assay. pLexA-POS expresses a LexA-GAL4AD fusion
protein, and was used as negative control in the repression assay. Both pRFHM1 and
pLexA-POS have a HIS3 marker for selection in the yeast cells. Transcriptional
repression of the LacZ gene by LexA- 181 was compared with the negative control
LexA-bicoid protein. All of the plasmids used in this study have an ampicillin marker for
selection in bacteria (Bartel & Fields, 1997).
\
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Table 1: Plasmids used in this study
Plasmid

Marker

Characteristic features
Has a LexA BD followed by the polylinker under the
control of ADH1 constitutive promoter. Used for cloning

PLexA

His3, AmpR

the coding sequence of the bait protein.

Gal1 promoter expresses nuclear localization domain,
transcriptional activation domain, HA epitope tag.
PB42-

Trp1, AmpR

Used for cloning the cDNA library.

empty
Used as a sensitive reporter plasmid in the LexA based
two-hybrid system. It has eight LexA operators followed by
p 8op-LacZ

Ura3, AmpR the lacZ reporter gene.
Expresses LexA-Gal4p fusion protein. Expresses LexA-

pLexA-pos

Gal4AD fusion protein, used as negative control for
His3, AmpR

repression assay.
Expresses LexA-bicoid fusion protein. Used as a positive

pRFHM1

R

His3, Amp

control for repression assay.
Has a UASG followed by two LexA operators followed by
lacz gene. Used in the repression assay for the detection of

pJK101

Ura3, AmpR the nuclear localization of the LexA fusion proteins.

pLexA- 181

His, Amp

Expresses LexA- 181 fusion protein

pB42-cDNA

Trp, Amp

Expresses B42-cDNA fusion proteins
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Fig. 2.1 pLexA vector. The human cDNA sequence encoding
was cloned into
multiple cloning site (MCS) of the pLexA vector to use as bait in yeast two-hybrid
screening. It has a LexA DNA BD and a constitutive ADH1 promoter that regulate the
expression of LexA fusion proteins. HIS3 is used as a marker for selection in yeast
(Gyuris et al., 1993). The ampicillin resistance gene, Ampr and the pBR origin allows
selection and replication in E.coli. The 2 plasmid origin allows replication in yeast.
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Fig. 2.2 pB42AD vector. The human fetal brain cDNA library was cloned into the MCS
of the pB42 vector to use as prey in the yeast two hybrid screening. It has a B42 AD and
the GAL1 inducible promoter regulates expression of cDNA-B42 fusion proteins. The
transcriptional terminator is derived from ADH1. A hemagglutinin epitop tag (HA) and a
nuclear localization signal are also present on the plasmid. TRP1 is used as a marker for
selection in yeast (Gyuris et al., 1993). The ampicillin resistance gene, Ampr and the pBR
origin allows selection and replication in E.coli. The 2 plasmid origin allows replication
in yeast.
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Fig. 2.3 p8op-LacZ plasmid. The LacZ gene is used as reporter of -galactosidase
activity. The LacZ gene is under the control of 8 lexA operators and a minimal TATA
region form the GAL1 promoter. URA3 is used as a marker for selection in yeast
(Estojak., 1995). The ampicillin resistance gene, Ampr and the pBR origin allows
selection and replication in E.coli. The 2 plasmid origin allows replication in yeast. The
ampicillin resistance gene, Ampr and the pBR origin allows selection and replication in
E.coli. The 2 plasmid origin allows replication in yeast.
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C. Cloning of 181 into the pLexA vector
Human cDNA corresponding to the sequence of 181 gene was synthesized by
Genescript (Genescript, Piscataway, NJ) and cloned into pUC57 with optimized codon
usage in E. coli. pUC57- 181 was used as the template for PCR amplification of 181
using the following primer pairs: gamma forward
(ATCCGGAATTCATGACCCGGGACGA) and gamma reverse
(ATCGCGGATCCCTATTCTGCAGATGG). Both primers contain restriction sites for
EcoRI and BamH1, which allowed the amplicon to be digested with restriction enzymes
EcoRI and BamHI (New England Biolabs) and ligated into precut pLexA with the same
restriction sites. The PCR reaction was carried out in a Techne TC-512 thermocycler for
25 cycles under the following conditions: initial denaturation at 94 oC for 1min,
denaturation at 94 oC for 1min, annealing at 60 oC for 2min, extension at 72 oC for 1min,
final extension at 72 oC for 5min. The insert and vector were combined in a 10:1 volume
ratio with T4 DNA ligase (Takara ligation kit) to carry out the ligation. The ligation mix
was incubated at 16 oC for 4 hrs. After incubation, the ligation mixture was directly
transformed into DH5 chemically competent cells by heatshock at 42 oC. Positive
clones were selected by plating the transformants on LB plates containing 100 g/ml of
ampicillin.

D. Yeast transformation
EGY 48 cells containing the p8op-LacZ plasmid were made competent by
growing 5 ml of overnight culture in synthetic media (SD) lacking uracil (SD-URA)
medium (Clonetech, Mountain View, CA) followed by subculturing into 300 ml of the
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same media. Subcultured cells were grown for 2-3 hours until mid log phase or an optical
density (OD) 0.4-0.5nm. Cells were resuspended in 1.5 ml of 0.1 M lithium acetate
(LiAc), 1M Tris-EDTA (TE) buffer and then shaken at 250 rpm for 30 min at 30 oC.
These competent cells were then used for the transformation of the bait and library
plasmids. The transformation mix was prepared by combining 1 g of plasmid DNA, 10
l of 10 mg/ml carrier salmon sperm DNA, 100 l of yeast competent cells, and 600 l
of 40% polyethylene glycol (PEG) solution (1X TE, 0.1M LiAc, 40% PEG). The
transformation mix was incubated at 30 oC for 30 min at 250 rpm, followed by the
addition of 70 l dimethyl sufoxide (DMSO) and heating at 42 oC for 15 min
(Matchmaker LexA two-hybrid system and Matchmaker LexA libraries user manual,
Clontech, Mountain View, CA). The cells were plated onto glucose based SD media
lacking uracil, histidine, tryptophan (SD-U-H-T) and incubated at 30 oC for 2-3 days until
colonies appeared. Glucose based synthetic media was used for normal maintenance of
the plasmids in yeast cells. Another synthetically derived media used in this study was
galactose/raffinose (SD gal/raf) based media which (Clontech, Mountain View, CA) was
used to induce the expression of the library proteins.

E. Isolation of LexA fusion proteins in the yeast cells
Five ml of overnight culture of EGY-48 cells containing the bait (pLexA- 181)
and reporter (p8op-LacZ) plasmids were grown in SD-U-H media, subcultured into fresh
SD-U-H media, and grown until they reached mid log phase (OD~ 0.5-0.7). One and a
half ml of culture was subjected to centrifugation for 3min at 13000xg and the resultant
pellet was resuspended in 500 l of 50 mM Tris HCl/ 10 mM NaN3, pH 8.0. Following a
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second centrifugation, the pellets were resuspended in 50 l of 2X SDS sample buffer
(containing 2 ml glycerol, 5% SDS, 0.25 M Tris-HCl, 40 l of 5 mg/ml bromophenol
blue, and 10% beta mercapto ethanol/10 ml). Samples were vortexed, boiled for 5 min,
and frozen quickly in dry ice or liquid N2. After adding 50 l more 2X SDS buffer, cells
were centrifuged at 13000xg for 5 min. The supernatant fraction was used for western
blotting.

F. Identification of LexA- 181 fusion protein expression in the EGY48 cells
Whole cell proteins were extracted from the yeast cells containing bait and prey
plasmids as mentioned above. After loading the samples onto a 4-20% polyacrylamide
gel (Nu Sep gels), the gel was subjected to electrophoresis at 200 V for 1 hour, after
which proteins were transferred to a PVDF membrane previously activated in 100%
methanol for 15 min. Transfer of proteins at 100V was performed in transfer buffer (25
mM Tris, 192 mM glycine, 10% methanol) for 1 hour. Following the transfer, the
membrane was blocked for 1 hour at room temperature with blocking solution (5% non
fat dry milk powder, Tris buffer saline (TBS; 20 mM Tris base and 137mM sodium
chloride, pH 7.6). The blocked membrane was rinsed with TBS for 15 min and then
incubated with rabbit polyclonal anti LexA (Millipore, Temecula, CA) antibody (1:20000
dilution in 1% milk/TBS/0.1% tween 20) for 1-2 hours at room temperature. The
membrane was washed three times with 1% milk/TBS/0.2% Tween-20 and then
incubated with a goat anti-rabbit polyclonal alkaline phosphatase conjugated secondary
antibody (1:10,000 dilution in 1% milk/TBS). Again the membrane was washed three
times for 10 min each with 1% milk/TBS/0.2% Tween-20. After a quick rinse with TBS,
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the membrane was incubated with 1ml of western blue stabilized substrate for alkaline
phosphatase (Promega, Madison, WI) until color developed. The resulting image of the
developed blot was scanned using a Hewlett-Packard Scanjet 4890.

G. Human fetal brain cDNA library amplification
The human fetal brain cDNA library cloned into pB42 was obtained from Dr.
Erica Golemis (Fox Chase Cancer Center). This construct required amplification prior to
library screening. Therefore, the vector was electroporated into high efficiency
electrocompetent Mega X DH10B T1R E.coli cells. Sixty l of electrocompetent cells
were combined with 0.5 l of pB42-cDNA library plasmid (60 ng/ l) into pre-chilled 0.1
cm electroporation cuvettes (Fisher Scientific). The cells were electroporated at 2.0KV,
200 ohm, 25 F by using the BIO-RAD gene pulser II apparatus. Immediately after
electroporation, 1 ml of SOC media (2% bacto tryptone, 0.5% bacto yeast extract, 0.2%
5M NaCl, 0.25% 1M KCl, 1% 1M MgCl2, 1% 1M MgSO4, 2% 1M glucose) was added
to the electroporated cells. The cells were grown for 1hour. Eighteen l of cells
representing three times the number of independent clones 3.5x106, from this
transformation were suspended in 51 ml of LB broth and then the entire mixture was
plated on 150 mm LB plates containing 100 g/ml of ampicillin (300 l/plate). After
incubation of the plates at 32 oC for 18 hrs, cells were collected from plates in 4 ml of LB
broth by scraping the cells off the plates. Plasmid was isolated from collected cells by
using the Qiagen maxi prep plasmid isolation kit (Qiagen, Valencia, CA).
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H. Library screening
EGY 48 cells containing bait (pLexA- 181) and reporter plasmid (p8op-LacZ)
were made competent as described above. pB42-cDNA library plasmids were
transformed into the competent cells. Approximately 25 transformation reactions were
carried out for library screening. For each transformation reaction, 10 l of pB42-cDNA
library plasmid (126 ng/ l), 10 l of 10 mg/ml carrier DNA, 70 l of competent cells,
and 600 l of a 40% PEG solution (1M TE, 0.1M LiAc, 40% PEG) were combined. The
transformation was carried out at as mentioned above. Cells were plated onto SD-U-H-T
plates and then incubated at 30 oC for 2-3 days until colonies appeared. All cells were
pooled into 5 ml of sterile water by gently scraping the colonies off each plate. Collected
cells were resuspended in 60% glycerol solution and frozen in 1ml aliquots. One ml of
the glycerol stock was diluted in 500 ml of galactose/raffinose lacking uracil, histidine,
and tryptophan (SD gal/raf -U-H-T) media and grown at 30 oC, 250 rpm for 12 hours to
induce the library. Approximately 12 SD gal/raf-U-H-T-L plates were plated with 107
cells for library screening. Plates were incubated at 30 oC for 2-3 days until colonies
appeared.

I. Chloroform-agarose overlay assay for detection of potential interactions
Colonies that appeared on SD gal/raf-U-H-T-L plates on day 3 of screening were
streaked onto SD gal/raf-U-H-T plates. After incubating the plates for 2-3 days, each
plate was overlaid with 10 ml of chloroform. The remaining chloroform was removed,
and each plate was overlaid with 7-10 ml of X-gal agarose (1% low melting agarose, 0.1
M NaHPO4 buffer pH 7.0, 0.25 mg/ml X-gal). Plates were incubated at 30 oC until color
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developed.

J. Rescue of library plasmid in the KC-8 bacteria
Plasmid DNA was isolated from the putative positive EGY-48 yeast colonies that
showed positive interactions during library screening by using the Zymoprep yeast
plasmid miniprep kit II (Zymoresearch, Orange, CA). Isolated plasmid DNA was
electroporated into KC8 cells (Clonetech, Mountain View, CA) by using 1 mm gap
cuvettes on BIO-RAD gene pulser II set to 1.8 KV, 10 uF, 600 ohm. After
electroporation, cells were plated on M9-TRP selection media (7.5 mM (NH4)2 SO4, 33
mM KH2PO4, 60 mM K2HPO4, 1.7 mM sodium citrate, 15 g agar, 1M MgSO4.7H2O,
20ml 20% glucose, 0.74 g URA dropout mix (Clontech, Mountain View, CA ), 2 ml 1%
thiamine HCl, and 50 g/ml ampicillin) to rescue the library plasmids. Plates were
incubated for 2-3 days at 37 oC until colonies grew. Because of the selection pressure the
cells effectively retained the library plasmid, but eliminated the bait as well as reporter
plasmid.

K. Redundancy determination
To determine any redundancy among the isolated clones the screened library
plasmids were digested with EcoRI and XhoI, or the frequent cutter HhaI (New England
Biolabs, Baverly, MA). Digested plasmid DNA was loaded onto 0.7% agarose gel
(containing 0.7% agarose, 2 l of ethidium bromide, 1X TBE buffer (0.089 M Tris,
0.089M borate, & 0.002 M EDTA) and then electrophoresed at 100 V for 1hour. The
restriction digestion pattern of inserts was compared with a 1kb DNA ladder (New
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England Biolabs, Baverly, MA) or identified based on similar digestion patterns. Gel
pictures were taken on an Alpha Innotech Fluorochem HD2 system.

L. Sequencing and identification of positive clones
Plasmid DNA was isolated from the putative positive clones and used for
sequencing. PCR reactions were carried out in a Techne TC-512 thermocycler by
combining 200 ng of plasmid DNA template, Big Dye terminator ready mix v3.1
(Applied Biosystems, Foster City, CA), 5 pM forward primer (CTC TGC TGA GTG
GAG ATG C), and sterile water. Cycling was performed for 25 cycles as follows:
denaturation at 96 oC for 30 sec, annealing at 50 oC for 15 sec, extension at 60 oC for 4
min. Following amplification, the amplicon DNA was precipitated twice by using 75%
isopropanol and dried in a speedvac. Each pellet was dissolved in 20 l formamide
buffer. Sanger’s dideoxy sequencing was performed and then samples were loaded on
the sequencer (ABI PRISM 3130 Genetic Analyzer). Following the sequencing, the
clones were identified by using the publicly available Gen Bank database such as
BLASTN and BLASTP (http://blast.ncbi.nlm.nih.gov/Blast.cgi).

M. Specificity testing
Specificity of the 181 with its interacting proteins was confirmed by
transforming the yeast cells containing the p8op-LacZ reporter plasmid with the
following plasmids: pLexA-Phk

encode the

subunit of Phk), pLexA-Phb N’

(encodes the N-terminus of the natural substrate of Phk), pLexA-Phb C’ (encodes the cterminal catalytic domain of the Phk substrate Pb) (Andreeva et al., 2002). Bait
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transformed cells were also transformed with each putative positive clone and then grown
on SD-U-H-T media at 30oC for 2-3 days. Positive transformants were streaked onto SD
gal/raf –U-H-T plates and then assayed for -galactosidase activity as described above.

N. Quantitative -galactosidase assay
The Galactostar reporter assay system (Tropix) was used for quantitative
measurement of -galactosidase activity in yeast cell lysates. The Galactostar system is
very sensitive due to the use of the chemifluorescent substrate, 1, 2 dioxetane (Applied
Biosystems Galacto star system protocol, pp 2-3). Five ml of an overnight yeast culture
grown in SD-U-H-T media was subcultured to induce library protein expression. Cells
were grown until they reached mid log phase (OD~0.5). One and a half ml of the culture
was centrifuged at 12000xg for 0.5 min and resuspended in 1X Z buffer (0.5 M sodium
phosphate pH 7.1, 50 mM KCl, 5 mM MgSO4). Cells were again pelleted and then
resuspended in 300 l of 1X Z buffer. Two quick freeze and thaw cycles were carried out
for 100 l of cells in liquid nitrogen. Cells were pelleted by centrifugation at 12,000xg
for 5 min at 4 oC. Reaction buffer mix (300 l) was added to 20 l of the supernatant.
The reaction buffer mix was prepared by 1:50 dilution of the substrate in reaction buffer
diluent (100 mM sodium phosphate pH 7.5, 1 mM MgCl2, and 5% sapphire-II enhancer).
The reaction mixture was incubated for 90 min and luminescence was measured by using
a TD 20/20 Turner luminometer for 10 sec. Relative light units were recorded for each
sample. Data was represented as Modified Miller Units (MMU): the average of the
relative light units normalized to the original yeast cell culture concentration (RLU/OD of
the culture).

RESULTS

A. Cloning and characterization of 181 bait
The yeast two-hybrid assay was performed to identify 181 interacting proteins in
vivo. Gamma 181, cloned into the pLexA vector, was used as bait, and a human fetal
brain cDNA library cloned into the pB42 vector was used as prey in the screening
process. To construct the pLexA-181 recombinant vector, PCR amplified, digested 181
product was cloned into precut pLexA vector. Results of the cloning indicated that out of
12 isolated colonies, 11 contain the 181 insert as confirmed by restriction digestion (Fig.
3.1). The presence of 181 in the pLexA vector was further verified by sequencing the
recombinant pLexA-181 plasmid.
Additionally, before starting the actual screening process, the bait fusion protein
(LexA-181) expression in EGY48 was verified by western blotting (Fig. 3.2). As seen in
Fig. 3.2, when probed with an anti-LexA antibody, LexA-181 was efficiently expressed
in the yeast, equal to or more than that of the positive control LexA-p53 protein. Another
protein used in this study, LexA-Bicoid was also efficiently expressed in the yeast cells.
In a two-hybrid study, all the proteins must be targeted to the nucleus since
transcriptional activity is to be quantified as a report of protein interactions. Even though
Brent and Ptasshne, (1984) showed that the LexA protein expressed in yeast is passively
transported into the nucleus, verification of bait nuclear localization is necessary. The
LexA-181 fusion protein nuclear localization was detected by a nuclear repression
assay.

32

33

Fig 3.1. Identification of positive clones containing 181 in pLexA vector. Plasmid
DNA was isolated from the positive clones and then digested with EcoRI & BamHI. Size
of the 181 was compared with the 1kb quick load DNA ladder (New England Biolabs).
Gel lanes are indicated as 1. Marker, 2. PCR amplification of pUC57-γ181 (positive
control), 3-14. Restriction digestion of plasmids isolated from positive clones, 15.
Restriction digestion of pLex-A vector (negative control).
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Fig. 3.2. Identification of LexA fusion protein expression in yeast cells. Whole yeast
cell proteins extracts were probed for LexA fusion proteins using an anti-LexA antibody
which recognizes the DNA binding regions of the LexA protein. Immunoblot was
performed with the yeast cell lysates containing the following fusion proteins: Lane 1,
Marker; Lane 2, LexA-p53; Lane 3 and 5, LexA-181; Lane 4, LexA-bicoid. Both the
positive control p53 and the 181 bait are expressed in EGY48 yeast.
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pJK101+ pLexA-bicoid

pJK101 + pLexA-181

pJK101+ pLexA-POS
Fig.3.3. Repression assay for nuclear localization of LexA-181. Nuclear localization
of 181 was identified by transcriptional repression of the LacZ gene. pLexA-181
transformed yeast cells repress the transcription of the reporter gene identified as light
blue color in the picture above.
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In this assay, LexA fusion proteins bound to the operator located in between the
UAS and transcriptional start site inhibited the transcriptional activation of the
downstream targets by the enhancers bound to the UAS. pJK101 plasmid has an UASG
followed by 8 LexA operators, followed by a lacZ coding sequence. Yeast cells were
transformed with pJK101, pLexA-181, pLexA-POS, or pLexA-bicoid in binary
combinations for the repression assay and then transcriptional repression of the LacZ
reporter gene was assayed. Nuclear localization of LexA-181 repressed the transcription
of the reporter gene comparable to the positive control, bicoid, a nonspecific Drosophila
transcription factor, indicating that LexA-181 efficiently localizes to the nucleus (Fig.
3.3). As the yeast two-hybrid system is based upon the reconstitution of a functional
transcription factor, checking for the autoactivation of the reporter genes (LEU2 and
LacZ) by the bait protein alone is crucial for this study as it could lead to false positives.
Autoactivation of the LexA-LEU2 gene by LexA-181 was tested by growing the yeast
transformants containing LexA-181 alone or LexA-181 with pB42 AD in SD gal/raf-UH-T-L. Negligible growth was observed by the above transformants indicating that
LexA-181 lacks the ability to auto activate the LexA-LEU2 reporter gene (Fig 3.4).

B. Fetal brain cDNA library amplification
A fetal brain cDNA library that represents 3.5x106 independent clones was
amplified prior to the screening process. During amplification the library was represented
three times the number of independent clones. To get such a high number of independent
clones the library was transformed into high efficiency electrocompetent cells DH10B
and then plated onto LB-AMP plates. Transformation efficiency was calculated as
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0.9x1010 CFU/g. The amplified cDNA library concentration was 1262 ng/l and its
purity (A260/280) was measured to be 1.88.

C. Library screening
To carry out the screening process, EGY48 yeast cells were transformed with the
LexA-181 bait, the fetal brain cDNA library in pB42AD and the p8OP-LacZ reporter
plasmid. Cells were plated on synthetic media lacking leucine for LEU2 selection.
Putative positive interactions were identified by leucine protorophy and further confirmed
by their phenotypic expression of -galactosidase activity on SD gal/raf –U-H-T+Xgal
media. Thirty seven putative positive interactions were observed based upon LEU2
reporter gene expression. Of these 37 putative positive clones, only twenty showed
positive interactions for the second reporter gene -galactosidase (Fig. 3.5). The relative
strength of interactions was determined based on the intensity of the blue color within a
24 hour period. Scores were given to each colony with (++++) representing the strongest
interactors and (+) being the weakest interactors (Table 2).
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SD-U-H + p8opLacZ
LexA-181
LexA-p53

SD-U-H-T
LexA-181+B42 empty LexA-p53+B42-T ag

SD gal/raf –U-H-L+ p8opLacZ
LexA-181
LexA-p53

SD gal/raf–U-H-T-L
LexA-181+B42 empty LexA-p53+B42-T ag

Fig. 3.4. Testing bait 181 for transcriptional activation of reporter gene LEU2.
Transcriptional activation of the reporter gene LEU2 was identified by growing either the
LexA-181 or LexA-181+B42AD transformed EGY48 cells on synthetic growth media
(SD-U-H-T) followed by transferring the cells to induction media (SD gal/raf –U-H-T-L)
for expression of library proteins. p53 and pB42-Tag vectors were used as control
plasmids. p8op-lacZ is the reporter plasmid.
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Fig. 3.5. Putative positive interactors of 181. A total of 37 colonies showed positive
interactions for leucine prototrophy. Interactions were further confirmed by the
expression of the second reporter gene -galactosidase. Of those 37 colonies, 20 of them
(labeled with numbers) were able to metabolize X-gal in the chloroform agarose overlay
assay, as shown above.
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S. No

Strength of interaction

1

Putative positive clones that are showing
positive interactions
25

2

27, 29, 30, 31, 32, 33, 35, 36, 37, 38

++

3

1, 3, 4, 5, 6, 9, 10, 14, 15, 18, 19, 20, 23

+

++++

Table 2. Phenotypic expression of -galactosidase by the identified putative positive
clones. Putative positive colonies that showed leucine prototrophy were grown in the SD
gal/raf-U-H-T selection media and phenotypic expression of the -galactosidase activity
of the individual colony was observed after 24 hours. Clone numbers and the strength of
their interactions, (++++) being the strongest, and (+) being the weakest interaction are
listed in the table.

In order to isolate the putative library plasmids from the yeast cells, positive
clones were grown on SD-TRP selection media for two generations to eliminate the bait
and reporter plasmids. Subsequently, plasmid DNA was isolated from yeast by using a
Zymoprep plasmid isolation kit and then retransformed into the E. coli strain KC8
bacteria by electroporation. Transformants were allowed to grow on M9-TRP selection
media. Following plasmid isolation from the KC8 bacteria, each library clone’s insert
size was determined by the restriction analysis of the plasmids with EcoRI and XhoI.
Based upon comparison to a 1kb DNA ladder, insert sizes ranged from 100-750 base
pairs (Fig. 3.6). Redundancy among the clones was also analyzed by digesting the
screened library plasmids with the frequent cutter HhaI. Seven nonredundant clones were
identified based on the restriction digestion pattern (Fig. 3.7). The unique nonredundant
clones were identified as clone 1, 5, 6, 9, 14, 25, and 35. All unique clones were
sequenced and then identified by comparision to known sequences in the Gen Bank
database by using the BLASTN search engine (Table 3). Of these 7 nonredundant clones,
3 of them were translatable: 1, 5 and 25. Clones 1 and 5 correspond to the ribosomal
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proteins L9, and L23, and 25 corresponds to the nuclear antigen 14 (NA14). The clone
showing the strongest interaction by -galactosidase screening showed maximum
sequence homology to NA14. Three of the redundant clones 9. 19 and 36 show no
sequence homology with any known transcripts or proteins. Column 1 in Table 3
indicates the strength of interactions of these proteins with 181. Since the
truncatedsubunit of Phk has kinase activity, we hypothesize that it may phosphorylate
the binding partners of 181 identified in this screen, such as ribosomal proteins, and
NA14. Therefore, by using the PhosK program for predicting high potential
phosphorylation sites in proteins (Bloom and Gammeltoft, 1999), we identified high
potential serine/threonine phosphorylation sites in the putative 181 binding partners.
RPL9, RPL23 and NA14 all contain anywhere from 2 to 5 high potential phosphorylation
sites for serine/threonine kinases (Fig. 3.8).
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Fig. 3.6. cDNA library insert size determination by restriction digestion. 20 putative
positive clones (Lanes 2-14) were digested with the restriction enzymes EcoRI and XhoI.
cDNA library insert sizes ranged from 100- 750 bp as observed from the 0.7% agarose
gel. Lane 1, NEB 1Kb DNA ladder; Lane 15, negative control pB42 vector.
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Fig. 3.7. Identification of redundant clones. Redundancy among the clones was
identified by digesting the screened library plasmids (Lanes 2-17) with the frequent cutter
HhaI. A total of seven unique clones was identified based on restriction digestion pattern
as observed in 1% agarose gel. Lane 1, NEB 1Kb DNA ladder; Lane 15, control vector
pB42.
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Table 3 Identification of isolated clones. Plasmids isolated from the putative positive
clones were sequenced and then a BLASTN analysis was performed. The majority of the
clones showed maximum sequence homology to ribosomal proteins.

Strength of
Interactions Library plasmid

+

++, +, ++,
++, ++

+,++

+

++

++++

+, +, ++

Transcripts
Homo sapiens ribosomal protein L23

1/1, 5/10

(RPL23)

2/5, 7/18, 13/31,
15/33, 19/37

Homo sapiens ribosomal protein L9 (RPL9),
transcript variant 1

6/14, 14/32

Homo sapiens mitochondrial ribosomal protein
L12 (MRPL12)

3/6

Homo sapiens peroxisome proliferator-activated
receptor alpha

17/35, 20/38

Homo sapiens T-box 3 (TBX3), transcript
variant 2

9/25

Homo sapiens Sjogren syndrome nuclear
autoantigen 1 (SSNA1)-aka NA14

4/9, 8/19, 18/36

No significant similarity found
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D. Quantification of LexA-181 interactions with the RPL9, RPL23, NA14
The relative strength of the interaction between 181 and each ribosomal protein
and NA14 was measured quantitatively by using 1, 2 dioxetane, a sensitive
chemifluorescent substrate for -galactosidase. To carry out the quantitative assay, prey
plasmids containing ribosomal proteins or NA14 coding sequences were retransformed
into yeast cells expressing pLexA-181 bait plasmid. When the 181 was assayed against
the ribosomal proteins, -galactosidase activity measured to be 12.0 and 8.8 MMU for
RPL23 and RPL 9, respectively. NA14, the strongest interactor with 181 in the overlay
assay, had -galactosidase activity measuring 10.4 MMU. Interestingly, results obtained
in the quantitative assay do not correlate with the overlay assay results. All activities
measured are not significantly different when compared with the empty vector control,
10.1 MMU (Fig.3.9). For further verification, the overlay assay was performed again
with the retransformed cells. As expected, NA14 again showed very strong interactions
with 181. Whereas the ribosomal proteins interact relatively weakly (Fig. 3.10).
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1

2

3

Fig. 3.8 Identification of high serine/threonine phosphorylation sites High potential
serine-threonine phosphorylation sites were observed in the 181 interacting proteins
RPL23 (1), RPL9 (2), NA14 (3).
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The discrepancy in the data may be due to variability in cell lysis. Yeast cell walls
are very tough. Permeabilization of the cell wall and extraction of the whole galactosidase enzyme expressed in the cells is very important in the chemiflurorescent
reporter assay system. Chloroform was used for permeabilization of the cell walls in the
overlay assay, whereas Z buffer (containing sodium phosphate and magnesium sulphate)
was used in the chemiflurorescent reporter assay. To eliminate the possibility that the
association of 181 with RPL9, RPL23, and NA14 was due to nonspecific interactions,
each protein was tested in binary combinations with three other proteins in the LexA
vector: Pb N’, the N-terminal regulatory domain of Pb; Pb C’, the C-terminal catalytic
domain of Pb; and Phk  Results from this specificity test (Fig. 3.11) revealed that Phk
interacts with RPL23, Pb N’ interacts with all three 181 interactors, and Pb C’
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interacts with RPl23 alone.

Fig. 3.9. Relative interaction affinities of RPL9, RPL 23, NA14 with 181. Gamma
181 was assayed with RPL9, RPL23, and NA14. Empty pLexA and pB42 vectors were
used as negative controls. Results are expressed as the mean ± S.E.M. of three separate
experiments each carried out in duplicate.
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Fig. 3.10. Repeat overlay assay. For reconfirmation of the strength of the interactions,
yeast cells containing pLexA-181 plasmid were transformed with NA14 (1), RPL23 (2),
RPL9 (3), and B42 (4). As shown in the picture, NA14 interacts strongly (1) in the
overlay assay. pB42 AD transformed cells (4) do not interact with the 181 protein.
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1. LexA-181+RPL23
2. LexA-181+NA14
3. LexA-181+RPL9
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1. LexA-Phb N’+RPL9
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2. LexA-Phb C’+NA14

2
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1. LexA-bicoid +RPL9
2. LexA-bicoid + NA14
3. LexA-bicoid + RPL23

Fig. 3.11. Specificity testing Specificity of the 181 interactors with the Phk , Pb N’,
Pb C, were identified by chloroform overlay assay. As shown above, Pb N’ interacts
nonspecifically with all three proteins tested, whereas Pb C’ interacts with RPL23, and
Phk  interacts with RPL9.

DISCUSSION

By using a yeast two-hybrid system we have identified novel interacting proteins
of the PHKG1 variant 181 as NA14, RPL9, and RPL23. NA14 is an autoantigen which
is recognized by autoimmune serum from patients with Sjogren’s syndrome.
Autoantibodies raised against nuclear, cytoplasmic and cell surface components are the
most common characteristic features in autoimmune diseases such as systemic lupus,
rheumatoid arthritis, and Sjogrens syndrome. Structurally, NA14 consists of a coiled-coil
domain and a basic C-terminal domain. Coiled-coil domains are characteristic of other
nuclear autoantigens. Immunofluorescence studies revealed that NA14 is localized to the
nucleus (Ramos-Morales et al., 1998). Even though NA14 lacks a nuclear localization
signal, it is transported into the nucleus either by interacting with another nuclear protein
or by passive diffusion because of its small size. NA14 is expressed in almost all tissues,
with its expression in testis being very high (Ramos-Morales et al., 1998).
The centrosomal deflagellation inducible protein (DIP13) of Chlamydomonas
reinhardtii shows 60% sequence homology to NA14. DIP13 is localized to the basal
bodies and cytoplasmic microtubules. Because of the sequence similarity of NA14 with
DIP13, cellular localization of the NA14 was reexamined using anti-DIP13 antibodies as
well as anti-NA14 antibodies, as both of them recognize NA14. Interestingly,
immunological studies showed that NA14 localizes to centrosomes and not to the nucleus
as previously reported (Pfannenschmid et al., 2002).
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The role of the NA14 in the centrosomes is currently unknown. Coimmunoprecipitation and yeast two-hybrid studies showed that NA14 interacts with
spastin, a centrosomal protein (Errico et al., 2004). Spastin triggers the depolymerization
of the central spindle microtubules by its microtubule severing activity. NA14 acts as an
adaptor protein and helps in targeting the spastin to the centrosomes, thus playing an
important role in microtubule dynamics (Errico et al., 2004). Posttranslational
modifications of NA14 are currently not known. However, PROSITE database analysis
revealed that it has consensus motifs for N-glycosylation, a casein kinase II
phosphorylation site, and a PKC phosphorylation site (Ramos-Morales et al., 1998).
Another major category of binding partners identified for 181 were ribosomal
proteins. All ribosomes, irrespective of their origin, contain RNA and proteins.
Prokaryotes have 70S type ribosomes whereas eukaryotes have 80S ribosomes. The RNA
to protein weight ratio is 2:1 and 1:1 for prokaryotes and eukaryotes, respectively (Spirin,
1999). Both large and small subunits of the ribosomes have several different protein
components. Proteins in large and small subunits are indicated by L and S respectively
followed by a number. Ribosomal proteins are integral components of the ribosomes.
Collectively, all of the proteins play a crucial role in the translation process. Assigning
function to ribosomal proteins is very difficult, but based on the position of these proteins
in the subunit, one can infer function in general terms. The ribosomal protein L9 is
critical for ribosome function because anti-RPL9 antibodies significantly reduce protein
synthesis (Nag et al., 1991). The crystal structure of the ribosomal protein L9 has been
well characterized by X-ray diffraction studies. It has bilobal structure with two
ribosomal binding domains that are connected to each other by long

helical coils. Both
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domains have conserved aromatic and basic amino acids that likely play an important
role in binding to the ribosomes. RPL9 helps in ribosomal assembly and maintains the
catalytically active conformation of the RNA molecule (Hoffman et al., 1994, 1996).
In addition to the traditional cell role of ribosomal proteins, a regulatory role for
RPL23 has been identified with respect to the transcription factor p53. p53 is a tumor
suppressor protein that primarily mediates transcription of several proteins involved in
cell growth arrest, apoptosis, and inhibition of angiogenesis, thus protecting the cells
from malignancy (Sharpless and DePinho, 2002; Vogelstein et al., 2000). Because of its
tumor suppressor function, tight regulation of p53 is very important for normal growth
and development of cells. One of the major players that regulates p53 activity in cells is
MDM2, a protein which blocks transcriptional activity of p53 (Momand et al., 1992).
MDM2 is a ubiquitin ligase and its interacation with p53 initiates the ubiquitination of
p53 leading to proteosomal degradation (Kubbutat et al., 1997, Honda et al., 1997).
Proper ribosomal assembly and function are very important for normal functioning of
cells. Stress on ribosomal biogenesis also regulates the p53-MDM2 feedback loop. In
response to ribosomal stress, RPL23 activates p53 by inhibiting its interaction with
MDM2 (Dai et al., 2004).
Posttranslational modification of ribosomal proteins is known to occur in
reticulocytes and liver cells. In vivo phosphorylation of ribosomal proteins in rabbit
reticulocytes has been shown by Kabat (1970). Traugh et al., (1993) successfully isolated
three different protein kinases from rabbit reticulocytes that phosphorylate proteins of the
40S as well as 60S subunits. Two of the kinases have similar substrate specificity; one is
dependent on cAMP for phosphotransferase activity, whereas the other is independent of
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cAMP (Traugh et al., 1973). Rabbit liver ribosomal proteins are also phosphorylated by
cAMP dependent kinases such as protein kinase I (PKI) and protein kinase II (PKII). PKI
is more efficient at phosphorylating the ribosomal proteins than PKII (Eil & Wool, 1973).
In this study, we have identified high potential serine/threonine phosphorylation sites in
the 181 interacting proteins RPL9, 23, and NA14 by using the publicly available
NetPhosK bioinformatic tool. Biological significance of the posttranslational
modifications of ribosomal proteins as well as NA14 is currently unknown.
It should be noted that reports from yeast two-hybrid studies, have shown that
ribosomal proteins are quite often identified as false positives. We also observed some
weak interactions among ribosomal proteins and 181. Since the identified interactions
were relatively weak, and because RPL9 and RPL23 both interact with many other
proteins nonspecifically, it is likely that they are false interactions.
When 181 was used to screen a human fetal brain cDNA library, we identified 3
major interacting proteins. Those 3 proteins were identified as ribosomal proteins L9,
L23 and NA14. The ribosomal proteins, as well as NA14, are unique proteins due to the
fact they do not have any known conserved domains. Previous work from our lab has
shown that an expressed recombinant 181 subunit is catalytically active in vitro against a
synthetic substrate called the S peptide, and its activity depends on phosphorylation by
protein kinase C (PK-C) (unpublished data). Based upon our results by NetPhoK
predictions, all 3 identified 181 interactors have potential serine/threonine
phosphorylation sites that could be phosphorylated by 181. Comparision of these sites
with the phosphorylation sites of S peptide (SDQEKRKQIS* VRGL) revealed that the
181 interacting proteins and the S peptide phosphorylatable seryl residue is surrounded

53
by conserved basic amino acid residues (Fig.4.1). The consensus sequence deduced from
the ribosomal proteins and NA14 has similar characteristic features as the in vitro
substrate S peptide.

*

R K Q I S V R G L

S peptide

R K I A S N R E F

NA14

R K M R S V R A H

RPL9

P L P N S A R GE

RPL23

Fig. 4.1. Sequence alignment of high potential phosphorylations sites. High potential
phosphorylation sites of 181 interacting proteins were compared with the artificial
substrate S peptide. Basic conserved amino acid residues surrounding the convertible
serine residue are marked in yellow boxes.

Furthermore, similarity in the substrate recognition site was observed in the case
of the Phk holoenzyme. Phk recognizes the consensus sequence K/R-X-X-S*-V/I-R
deduced from its natural substrates such as Pb, glycogen synthase and the

subunit of

Phk itself (Pearson & Graves, 1991). Basic amino acid residues surrounding the serine
residue are very important in substrate recognition. Arginine at P+2 activates Phk (PickettGies and Walsh, 1986 b). Since the amino acids surrounding the serine residue in all
three identified proteins show a similar pattern as the in vitro substrate S peptide, it is
possible these ribosomal proteins and the NA14 are phopshorylated by 181 in vivo.
Comparison of the full length and truncated gamma subunit’s structures, as
predicted by using the I-TASSER folding program (Zhang, 2008, unpublished data),
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reveal that 181 lacks much of the kinase helical domain. As a result, we anticipated that
from this study we would potentially identify some binding partners that might
compensate for the loss of the helical domain and help in orienting substrates to the
catalytic site of 181. Additionally, since the unique C terminal 21 amino acids of 181
contains the phosphorylation site for PK-C, we also expected to identify PK-C as an
associated protein in our screen. Contrary to these predictions, we did not identify PK-C
nor other proteins which may serve as adaptor or subunits in a larger complex.
Alternatively, the three proteins that were identified appear to be potential substrates for
the enzyme, although again, it is probable that the ribosomal proteins are false positives.
Further research is needed to confirm phosphorylation of NA14 by 181. If 181 does
not phosphorylate NA14, then we need to think about the physiological importance of
this interaction in the brain. Previous reports say that NA14 acts as an adapter protein that
helps in the localization of spastin to centrosomes. It is possible that interactions between
181 and NA14 might cause conformational changes in the NA14 resulting in the
exposure of known hydrophobic domains that play an important role in its interaction
with spastin.
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